Atos multiplies supercomputing capacity by 12 at CESGA in Spain with new “Finisterrae III”

Santiago de Compostela (Galicia, Spain), Paris (France) July 29, 2021 Atos has been selected by the…

Destiny Pharma PLC making significant strides towards phase III evaluation of potential breakthrough C.diff treatment

CEO Neil Clark explained: “We have manufactured important progress considering the fact that closing the £10.4mln…

AstraZeneca vaccine shows 79{744e41c82c0a3fcc278dda80181a967fddc35ccb056a7a316bb3300c6fc50654} efficacy in phase III trial

(Image by Halfpoint Illustrations or photos/Getty Illustrations or photos) AstraZeneca’s COVID-19 vaccine has just undergone a…